Home >Products> Spectrum | HPLC | GC | MS >HPLC / FPLC > Sepax Zenix SEC Columns
Spectrum | HPLC | GC | MS:  Spectrophotometers   HPLC / FPLC   Gas Chromatograph   Mass Spectrometers   Gas Generator Systems   Ultraviolet Detectors  
Sepax Zenix SEC Columns
Sepax Zenix SEC Columns
Place of Origin:
United States
Brand:
Sepax Technologies, Inc.
Model:
Sepax Zenix SEC-80,Sepax Zenix SEC-100,Sepax Zenix SEC-150,Sepax Zenix SEC-300
Price:
Hits:
1638 
Updated:
4/1/2013
  • Product Detail
  • Company Profile

    Description 

    Made of 3 µm silica particles, Zenix SEC packing is a breakthrough technology for size exclusion chromatography. 

    Combination of 3 µm silica particle size and proprietary surface technology enables highest separation efficiency

     and resolution for biological molecules and water soluble polymers. Available pore sizes of Zenix packings are 

    100, 150 and 300Å.

    Sepax SEC Product Family Comparison Chart

    Product Line SRT® Zenix SRT®-C Zenix-C
    Particle size 5 µm 3 µm 5 µm 3 µm
    Pore size (Å) 100, 150, 300, 500, 1000 & 2000 80, 100, 150, 300 100, 150, 300, 500, 1000 & 2000 80, 100, 150, 300
    Resolution High Highest, Short column for faster separation High Highest, Short column for faster separation
    Efficiency High Doubled from 5µm High Doubled from 5µm
    Selectivity Same for SRT® and Zenix™ Same for SRT®-C and Zenix™-C
    Surface structure Chemically bonded stand-up monolayer Chemically bonded lay-down monolayer
    Recommended Sample Types Monoclonal antibodies, proteins, peptides, nucleic acids, oligonucleotides, virus, and water-soluble polymers "Tough samples" such as hydrophobic proteins like insulin, membrane protein monoclonal antibodies derivatized with polymer branches, e.g. polypeptide, PEG.
     

     


     

    Packing 

    Zenix S

     

    EC Technical Specifications

    Phase

    Zenix SEC-80

    Zenix SEC-100

    Zenix SEC-150

    Zenix SEC-300

    Material

    Neutral, hydrophilic film bonded silica

    Particle size

    µm

    Pore size

    ~ 80 Å

    ~ 100 Å

    ~ 150 Å

    ~ 300 Å

    Protein MW range (native)

    100 - 50,000

    100 - 100,000

    500 - 150,000

    5,000 - 1,250,000

    pH stability

    2 - 8.5 (pH 8.5-9.5 can be tolerated temporarily.)

    Backpressure (psi for a 7.8×300 mm)

    ~ 1,500

    ~ 1,500

    ~ 1,500

    ~ 1,500

    Maximum backpressure (psi)

    ~ 4,500

    ~ 4,500

    ~ 4,500

    ~ 3,500

    Salt concentration range

    20 mM - 2.0 M

    Maximum temperature (°C)

    ~ 80

    Mobile phase compatibility

    Aqueous and organic

    Characteristic

    Particle size of 3 µm

    Selection of pore size: 80, 100, 150 and 300 Å

    Highest separation efficiency and resolution

    High loading capacity

    High stability over low and high concentration salt

    Lot-to-lot reproducibility

    High protein recovery with intact biological activity

    Negligible non-specific interactions

    Ideal for separation and analysis of biological molecules: proteins, nucleic acids, oligonucleotides, 

    peptides and virus

    Ideal for separation and analysis of natural polymers, e.g. polysaccharides, synthetic polymers,

     and nanomaterials, e.g. nanoparticles

     

    Conditions  
    Column: Zenix SEC-300 (3 µm, 7.8×300mm)
    Mobile phase: 150 mM phosphate buffer, pH 7.0
    Flow rate: 1.0 mL/min
    Temperature: Ambient
    Detector: UV 214 nm
    Injection volume: 5 µL
    Sample: 1. Thyroglobulin (1.0 mg/mL), 670 kD
    2. BSA dimer, 132 kD
    3. BSA (1.0 mg/mL), 66 kD
    4. Ribonuclease A (1.0 mg/mL), 13.7 kD
    5. Uracil (0.1 mg/mL), 120 D

    Pore size vs. MW exclusion limit

    Phases (3 µm) Pore Size Protein MW Exclusion Limit
    Zenix SEC-80 80 Å 50,000
    Zenix SEC-100 100 Å 100,000
    Zenix SEC-150 150 Å 150,000
    Zenix SEC-300 300 Å 1,250,000

    Column Dimension Availability

    Available Zenix SEC column dimensions are 0.75, 1.0, 2.1, 3.0, 4.6, 7.8, 10, 21.2 and 30 mm I.D., and 20, 30, 50, 100, 150, 250, 300 and 600 mm length. Sepax also offers custom-made columns. Both stainless steel and PEEK tubes are available.

    High Separation Efficiency

    The advantages of developing small particle size are higher efficiency and higher resolution. When particle size is decreased to 3 µm from 5 µm, the column efficiency is almost doubled. As shown in Table 1, the plate numbers of BSA dimmer, BSA, ribonuclease A increased from 2720 to 4600, 6590 to 13090, 11160 to 22000 when the particle size decreased from 5 µm to 3 µm. Fig. 2 and Fig. 3 further show that high efficiency has been achieved by 3 µm Zenix columns with various proteins. The efficiency of p-aminobenzoic acid reached to the plate number of 40,000 for 30 cm long Zenix column.

    Figure 1. Separation of protein mixture A by Zenix SEC-300 and SRT SEC-300 columns. 

    Conditions  
    Column: Zenix SEC-300 and SRT SEC-300
    Mobile phase: 150 mM phosphate buffer, pH 7.0
    Flow rate: 1.0 mL/min for 7.8×300mm, 0.35 mL/min for 4.6×300mm
    Temperature: Ambient
    Detector: UV 214 nm
    Injection volume: 10 µL for 7.8×300mm, 3 µL for 4.6×300mm
    Sample: 1. Thyroglobulin (1.0 mg/mL), 670 kD
    2. BSA dimer, 132 kD
    3. BSA (1.0 mg/mL), 66 kD
    4. Ribonuclease A (1.0 mg/mL), 13.7 kD
    5. Uracil (0.1 mg/mL), 120 D

    Table 1. Efficiency of Zenix SEC-300 and SRT SEC-300 columns. 
     

    Peak Protein Zenix 300 (4.6×300) Zenix 300 (7.8×300) SRT 300 (7.8×300)
    1 Thyroglobulin 2180 1730 1120
    2 BSADimer 4390 4600 2720
    3 BSA 10280 13090 6590
    4 Ribonuclease A 16490 22000 11160
    5 Uracil 33640 38500 27860

    Figure 2. Separation of protein mixture B by Zenix SEC-150 and 300 columns with 7.8 mm ID. 
     

    Conditions  
    Column: 3 µm, 7.8×300mm
    Mobile phase: 150 mM phosphate buffer, pH 7.0
    Flow rate: 1.0 mL/min
    Temperature: Ambient
    Detector: UV 214 nm
    Injection volume: 10 µL
    Sample: 1. Thyroglobulin, 670 kD
    2. γ-Globulin, 158 kD
    3. Ovalbumin, 44 kD
    4. Ribonuclease A, 13.7 kD
    5. p-Aminobenzoic acid, 137 D
     

    Table 2. Efficiency of 7.8×300 mm Zenix SEC-150 and 300 columns. 
     

    Peak Protein Zenix 150 Zenix 300
    1 Thyroglobulin 12420 1295
    2 γ-Globulin 2860 3650
    3 Ovalbumin 6620 11760
    4 Ribonuclease A 16450 21690
    5 p-Aminobenzoic acid 40550 39400

    Figure 3. Separation of protein mixture B by Zenix SEC-150 and 300 columns with 4.6 mm ID. 
     

    Conditions  
    Column: 3 µm, 4.6×300mm
    Mobile phase: 150 mM phosphate buffer, pH 7.0
    Flow rate: 0.35 mL/min
    Temperature: Ambient
    Detector: UV 214 nm
    Injection volume: 5 µL
    Sample: 1. Thyroglobulin, 670 kD
    2. γ-Globulin, 158 kD
    3. Ovalbumin, 44 kD
    4. Ribonuclease A, 13.7 kD
    5. p-Aminobenzoic acid, 137 D
     

    Table 3. Efficiency of 4.6×300 mm Zenix SEC-150 and 300 columns. 
     

    Peak Protein Zenix 150 Zenix 300
    1 Thyroglobulin 6020 2410
    2 γ-Globulin 2560 3000
    3 Ovalbumin 6030 10260
    4 Ribonuclease A 13350 17020
    5 p-Aminobenzoic acid 35500 33480

    High Loading Capacity

    Loading capacity is critical for size exclusion separation and purification. Figure 4 shows high loading capacity for BSA as one example (>500 µg for an analytical column). 
    Figure 4. BSA loading test on a Zenix SEC-150 column. 

    Conditions  
    Column: Zenix SEC-150 (3 µm, 7.8×300 mm)
    Mobile phase: 150 mM phosphate buffer, pH 7.0
    Flow rate: 1.0 mL/min
    Temperature: Ambient
    Detector: UV 214 nm
    Injection volume: 10 µL

    Figure 5. BSA loading test on a Zenix SEC-300 column. 
     

    Conditions  
    Column: Zenix SEC-300 (3 µm, 7.8×300 mm)
    Mobile phase: 150 mM phosphate buffer, pH 7.0
    Flow rate: 1.0 mL/min
    Temperature: Ambient
    Detector: UV 214 nm
    Injection volume: 10 µL

    High Stability

    The proprietary stationary phases of Zenix SEC packings utilize densely bonded chemistry on the silica surface, which greatly hinders the diffusion of the molecules that would attack the bond of silica-stationary phase layer, thus enabling high stability over a wide range of pH from 2 to 8.5.

     


    Conditions  
    Column: Zenix 3 µm, 7.8×300 mm
    Mobile phase: 150 mM phosphate buffer, pH 7.0
    Flow rate: 1.0 mL/min
    Temperature: Ambient
    Injection volume: 10 µL
    Sample: A) BSA
    B) Thyroglobulin (1.0 mg/mL)
        BSA (1.0 mg/mL)
        Ribonuclease A (1.0 mg/mL)
        Uracil (2.5 mg/mL)

    Mobile Phase Compatibility

    Zenix SEC phases are compatible with most aqueous buffers, such as ammonium acetate, phosphate, trizma and so on. Zenix SEC phases can tolerate high concentration of salts, such as 2.0 M. Furthermore, Zenix SEC columns are stable in both organic solvents, such as methanol, ethanol, THF, DMF, DMSO, and so on; as well as the mixture of water and organic solvents.

    Lot-to-Lot Reproducibility

    The controlled surface chemistry used to synthesize Zenix SEC phases makes the surface coating highly reproducible, leading to consistent column manufacturing. Separation variation from batch to batch is controlled to be within 5% for retention time.

     

    Conditions  
    Column: Zenix SEC-300 (3 µm, 7.8×150mm)
    Mobile phase: 150 mM phosphate buffer, pH 7.0
    Flow rate: 1.0 mL/min
    Temperature: Ambient
    Detector: UV 214 nm
    Injection volume: 10 µL
    Samples: 1) Thyroglobulin, 2) BSA dimer, 3) BSA, 4) Ribonuclease A, 5) Uracil

    High Protein Recovery

    Zenix SEC phases are hydrophilic and neutral. Proteins and other biological molecules have negligible nonspecific interactions with Zenix stationary phases. The protein adsorption to the silica surface is suppressed, leading to high recovery of intact proteins, maintaining the protein activity after separation. More than 95% recovery is achieved for BSA and lysozyme, the representatives for acidic and basic proteins, respectively.

    bio-equip.cn
    Profile

    Sepax Technologies, Inc., a privately held company, was founded in Delaware, USA in November 2002. It develops and manufactures HPLC consumables, bulk media, and equipment in liquid chromatography for chemical and biological separations. It is a fast growing technology company and owns patents, proprietary technologies and know-how. Sepax has emerged as a leader in the biological separation industry in the global market.
    Business strategies

    Sepax Technologies, Inc. develops innovative HPLC consumables, bulk media, and instruments to solve separation challenges in the global market. We provide solution-based products by closely working with our customer scientists in pharmaceuticals, biopharmaceuticals, research institutes and government labs. Our strong technical team develops various methods with our customers to analyze complex biological molecules. As a leader in the biological separation industry, we constantly develop the best bio-separation technologies and products for our global customers. We have reached a competitive position globally in fast growing regions.
    Vision Statement

    To become a technology leader in the biological separation industry in the global market and provide solution based products and services for our customers.
    Operation

    Sepax Technologies, Inc.
    Our company headquarter in Delaware is located in Delaware Technology Park with facilities of 15,000 ft2 dedicated to the development of separation resin technologies and instrumentation, production of HPLC resins, columns and CE consumables. It is also the marketing and sales center for our US and global markets.


    Sales
    Domestic
    Audrey Fisher
    Field Sales Account Manager
    (Northern CA areas, UT, CO, OR)
    Direct Phone: 925-324-5223
    Email: afisher@sepax-tech.com
    Kathleen Falls
    West Coast Regional Manager
    (All other CA areas, WA, TX, AZ, NM, MI)
    Direct Phone: 323-228-0004
    Email: kfalls@sepax-tech.com
    Michael Hunnewell
    Field Sales Account Manager
    (MA, RI, NH, CT, NY)
    Direct Phone: 302-650-3955
    Email: mhunnewell@sepax-tech.com
    Colleen Callahan
    Midwest Account Manager
    (WI, IL, IN, OH, MO)
    Direct Phone: 302-366-1101, ext 106
    Cell Phone: 302-339-8747
    Email: ccallahan@sepax-tech.com
    All other areas, please contact
    Helen Gu
    Vice President, Sales
    Direct phone: 302-650-3909
    Email: hgu@sepax-tech.com
    International
    Tingting Wu
    Executive Account Manager/Marketing
    Phone: 302-366-1101, ext 115
    Email: twu@sepax-tech.com
Request Information
Request Information: yes no
Request Quotation: yes no
refresh

I agree to share my inquiry with the other matching suppliers.

Request Information

* Name:
Job Title:
* Tel:
Fax:
* E-mail:
Postcode:
Institution/Company:
Address:
* Country:
Request Information:
yes no
Request Quotation:
yes no
* Message:
* Verification Code:
refresh
I agree to share my inquiry to the other matching suppliers.